home / stock / htd / htd news


HTD News and Press, John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

Stock Information

Company Name: John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest
Stock Symbol: HTD
Market: NYSE

Menu

HTD HTD Quote HTD Short HTD News HTD Articles HTD Message Board
Get HTD Alerts

News, Short Squeeze, Breakout and More Instantly...

HTD - HTD: Utility And Fixed-Income Exposure At A Discount

2024-07-16 11:49:45 ET Summary John Hancock Tax-Advantaged Dividend Income Fund provides investors exposure to the utility sector and fixed-income investments. HTD has performed well recently and still offers an attractive discount to its NAV for investors. The fund's distribu...

HTD - BXSY: A Unique CEF, But A Poor Performance History

2024-07-15 14:07:55 ET Summary Bexil Investment Trust is a closed-end fund with a 93.90% total return over the past ten years, despite a 19.82% share price decline. The BXSY CEF focuses on dividend-paying value stocks, which have substantially underperformed growth stocks over the...

HTD - When the Price of (HTD) Talks, People Listen

2024-07-12 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HTD - My 9.5% Income Portfolio - Harvesting Dividends

2024-07-08 16:47:30 ET Summary Like drops of delicious wine, in March 2014 came the dividends of the first ETFs I purchased, with which I began my adventure in the U.S. market. From the small sips of that portfolio to the current dividends/distributions, the trek has been a long o...

HTD - (HTD) Proactive Strategies

2024-07-02 05:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HTD - Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions

Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...

HTD - (HTD) Pivots Trading Plans and Risk Controls

2024-06-22 06:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HTD - HTD: Utilities Exposure Presents Rate Sensitivity

2024-06-18 22:58:04 ET Summary John Hancock Tax-Advantaged Dividend Income Fund offers investors an 8.4% yield in a tax-friendly manner through preferred stocks and use of return of capital. HTD's exposure to the utilities sector presents some weakness amidst the higher interest r...

HTD - Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome)

MENLO PARK, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the...

HTD - (HTD) Trading Report

2024-05-31 15:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Next 10